Research Article - (2015) Volume 5, Issue 3
Safety and Efficacy of High-dose Tumor Necrosis Factor (TNF) Inhibitors in the Management of Pediatric Inflammatory Diseases
- Aliese Sarkissian1 and James D Birmingham2*
- 1Grand Rapids Medical Education Partners/Michigan State University Pediatrics Residency, 1000 Monroe Ave. NW, Grand Rapids, MI 49503, USA
- 2Adult and pediatric rheumatologist, Section Chief of Helen DeVos Children’s Hospital Pediatric Rheumatology, 35 Michigan St NE, Suite 4150, Grand Rapids, MI 49503, USA
*Corresponding Author:
James D Birmingham, MD, 1155 East Paris Ave SE, Suite 100, Grand Rapids, MI 49546, USA, Tel: 6164598088, Fax: 6164598312
Email:
